10
Views
3
CrossRef citations to date
0
Altmetric
Articles

Prophylactic Administration of Amoxicillin and Clavulanic Acid in Pregnant Women with Premature Rupture of the Membranes

Pages 290-294 | Published online: 18 Jul 2013

REFERENCES

  • Nelson LH, Meis PJ, Hatjes CG, Ernest JM, Dillard R, Schey HM. Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase and expectant management. Obstet Gynecol 1985; 66: 55–8.
  • Schmidt PL, Sims ME, Strassner HT, Paul RH, Muller E, McCant D. Effect of antepartum glucocorticoid adminis-tration upon neonatal respiratory distress syndrome and pen-natal infection. Am J Obstet Gynecol 1984; 148: 178–86.
  • Christensen KK, Ingemarsson I, Leideman T, Solum H, Srenningsen N. Effect of ritodrine on Labor after premature rupture of the membranes. Obstet Gynecol 1980; 55: 187–90.
  • Iams JD, Talbert MC, Barcows H, Sachs L. Management of preterm prematurely ruptured membranes: a prospective randomised comparison of observation versus use of steroids and timed delivery. Am J Obstet Gynecol 1985; 151: 32–38.
  • Morales WJ, Diebel D, Lazar AJ, Ladrozny D. The effect of antenatal dexamethasone administration on preven-tion of respiratory distress syndrome in preterm gestations with premature rupture of membranes. Am J Obstet Gynecol 1986; 154: 591–5.
  • Dunlop PDM, Crowley PA, Lamont RF, Hawkins DF. Preterm ruptured membrans, no contractions. J Obstet Gynecol 1986; 7: 92–96.
  • Lebherz TB, Hellman LP, Madding R, Anctil A, Avje SL. Double-Blint study of premature rupture of the mem-branes. Am J Obstet Gynecol 1963; 87: 218–25.
  • Amon E, Lewis SB, Sibai BM, Villar M, Arheart KL. Ampicillin prophylaxis in preterm premature rupture of the membranes: a prospective randomized study. Am J Obstet Gynecol 1988; 159: 539–43.
  • Morales WJ, Angel JL, O'Brien WF, Knuppel RA. Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study. Obstet Gynecol 1989; 73: 721–26.
  • Debodinance P, Parmentier D, Devulder G, Closset P, Querleu D, Crepin G. Can one reduce the risk of neonatal infection after premature rupture of the membranes? J Gynecol Obstet Biol Reprod (Paris) 1990; 19: 533–37.
  • Johnston MM, Sanchez-Ramos L, Vaughn AJ, Todd MW, Benrubi GI. Antibiotic therapy in preterm rupture of membranes: a randomized, prospective, double-blind trial. Am J Obstet Gynecol 1990; 163: 743–47.
  • McGregor JA, French JI, Seo K. Antimicrobial therapy in preterm premature rupture of membranes: results of a prospective, double-blind, placebo-controlled trial of ery-thromycin. Am J Obstet Gynecol 1991; 165: 632–40.
  • Mercer BM, Moretti ML, Prevost RR, Sibai BM. Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients. Am J Obstet Gynecol 1992; 166: 794–802.
  • Christmas JT, Cox SM, Andrews W, Dax J, Leveno KJ, Gilstrap LC. Expectant management of preterm ruptured membranes: effects of antimicrobial therapy. Obstet Gynecol 1992; 80: 759–62.
  • Kurki T, Hallman M, Zilliacus R, Teramo K, Ylikorkala 0. Premature rupture of the membranes: effect of penicillin prophylaxis and long-term outcome of the children. Am J Perinatol 1992; 9: 11–16.
  • Lockwood CJ, Costigan K, Ghidini A, et al. Double-blind, placebo-controlled trial of piperacillin prophylaxis in preterm membrane rupture. Am J Obstet Gynecol 1993; 169: 970–76.
  • Owen J, Groome LH, Hauth JC. Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture. Am J Ostet Gynecol 1993; 169: 976–81.
  • Blanco J, Iams J, Artal R, et al. Multicenter double-blind prospective random trial of ceftizoxime vs placebo in women with preterm premature ruptured membranes (pPROM). Am J Obstet Gynecol 1993; 168: 378.
  • Newton ER, Prihoda TJ, Gibbs RS. Logistic regression analysis of risk factors for intraamniatic infection. Obstet Gynecol 1989; 73: 571–5.
  • Newton ER, Prihoda TJ, Gibbs RS. A clinical and microbiological analysis of risk factors for puerperal endometritis. Obstet Gynecol 1990; 75: 402–6.
  • Roney Y, Artal R. C-reactive protein as a predictor for chorio-amnionitis in cases of premature rupture of the mem-branes. Am J Obstet Gynecol 1984; 150: 546–8.
  • Tampakoudis P, Kalachanis J, Krommidas A, Fraguli E, Panagiotidou A, Kyrou A, Mantalenakis S. The value of “C-reactive protein” in the diagnosis of chorioamnionitis in cases of premature rupture of the membranes. Bull Physio-Pathol Reprod Artificial Insemination, 1991; 10: 14–18.
  • Perkins RP, Thou SM, Butler C, Skipper BJ. Histologic chorio-amnionitis in pregnancies of various gestational ages. Obstet Gynecol 1987; 70: 856.
  • Hardt NS, Konstenbauder M, Ogburn M, Behnke M, Resnick M, Cruz A. Influence of chonoamnionitis on long-term prognosis in low birth weight infants. Obstet Gynecol 1985; 65: 5.
  • Hautch JC, Gilstrap KK, Hankins GDV, Connor KD. Term maternal and neonatal complications of acute chorioamnionitis. Obstet Gynecol 1985; 66: 59–61.
  • Ohlsson A. Treatments of preterm premature rupture of the membranes: a meta-analysis. Am J Obstet Gynecol 1989; 160: 820–906.
  • Mercer BM, Arheart KL. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes. Lancet 1995; 346: 1271–79.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.